-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB BIOTHERAPEUTICS INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING: TARGET PRICE $7

Reuters·09/17/2025 10:22:18

Please log in to view news